USP53 Regulates Bone Homeostasis by Controlling Rankl Expression in Osteoblasts and Bone Marrow Adipocytes

Area of Science:

• Skeletal Biology and Bone Metabolism
• Molecular Mechanisms of Bone Remodeling
• Gene Function in Skeletal Development

Background:

• Bone homeostasis relies on synchronized osteoblast and osteoclast activity.
• Understanding bone remodeling mechanisms is key to addressing bone disorders.
• The role of ubiquitin-specific peptidase 53 (Usp53) in bone biology was previously unexplored.

Purpose of the Study:

• To investigate the function of Usp53 in skeletal development and bone homeostasis.
• To elucidate the molecular mechanisms by which Usp53 influences bone remodeling.
• To determine the impact of Usp53 deficiency on bone mass and mechanical properties.

Main Methods:

• Generation and analysis of Usp53 null mice.
• In vivo micro-computed tomography (micro-CT) for bone parameter assessment.
• Cellular analysis of osteoblast and osteoclast activity, including osteoclastogenesis.
• Measurement of serum receptor activator of NF-κB ligand (RANKL) levels.
• Investigation of Usp53's interaction with VDR and SMAD3.

Main Results:

• Usp53 null mice exhibit significantly reduced trabecular and cortical bone mass and compromised mechanical properties.
• Ablation of Usp53 perturbs bone remodeling, increases osteoclast numbers, and augments osteoblast-dependent osteoclastogenesis.
• Usp53 deficiency leads to elevated serum RANKL levels and increased Rankl expression in osteoblasts and adipocytes.
• USP53 regulates Rankl expression by enhancing VDR-SMAD3 interaction.

Conclusions:

• Usp53 is a novel regulator of osteoblast-osteoclast coupling and bone homeostasis.
• USP53 plays a critical role in skeletal development and maintaining bone integrity.
• Further investigation of USP53 in bone pathologies is warranted.